Article Text

Download PDFPDF
Prevention and treatment of CVD: a new priority for the NHS
  1. Matt Kearney
  1. National Clinical Director for Cardiovascular Disease Prevention, NHS England, London, UK
  1. Correspondence to Dr Matt Kearney, NHS England, London SE1 6LH, UK; matt.kearney{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

With publication of the NHS Long Term Plan1 in January this year, cardiovascular disease (CVD) has been flagged as a new strategic priority for the NHS. The Plan was developed in response to the prime minister's commitment to increase spending on the NHS by £20 billion over the next 5 years. The objective is to use this new investment to transform healthcare and outcomes by doing things differently, with a comprehensive new service model in primary and community care, with increased personalisation, digital transformation and better integration to reduce pressure on emergency services.

CVD has been identified as a priority because of its huge impact on population health.2 It affects almost 7 million people in England, it is responsible for a quarter of …

View Full Text


  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.